| 5.20 Data as of 4:01pm ET |  -0.01 / -0.19%Today’s Change | 4.71 Today|||52-Week Range 6.80 | +0.19% Year-to-Date |
| PLX July Options Begin Trading May 20 / TheStreet.com |
| Previous close | 5.21 |
| Today’s open | 5.19 |
| Day’s range | 5.12 - 5.25 |
| Volume | 145,748 |
| Average volume (3 months) | 167,249 |
| Market cap | $487.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +69.77% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +1,059.84% |
| P/E ratio | NM |
| Price/Sales | 13.70 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| HPTXHyperion Therapeutic... | +0.16 | +0.79% |
| OSIROsiris Therapeutics ... | +0.09 | +0.82% |
| NVAXNovavax Inc | -0.01 | -0.49% |
| SZYMSolazyme Inc | -0.11 | -1.02% |
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $34.4M |
| Annual profit (last year) | -$11.6M |
| Net profit margin | -33.75% |
Sector Health Services |
Industry Services to the Health Industry |
President, Chief Executive Officer & Director David Aviezer, PhD, MBA |
Chief Operating Officer Tzvi Palash |
Corporate headquarters Carmiel, -- |
.
